ClinicalTrials.Veeva

Menu

A Pilot Study to Determine a Candidate Protocol for Transcranial Electrical Stimulation in the Treatment of Anxiety

U

University of Eastern Finland

Status

Unknown

Conditions

Anxiety

Treatments

Device: NeuroConn DC Stimulator Plus, tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT02321891
OptES-Anx-pilot

Details and patient eligibility

About

The investigators examine the efficacy of two different transcranial direct current stimulation (tDCS) stimulation protocols in the treatment of anxiety in an open-label pilot study.

Full description

The investigators examine the efficacy of two different transcranial direct current stimulation (tDCS) stimulation protocols in the treatment of anxiety in an open-label pilot study in patients with chronic pain. The investigators also seek to detect autonomic nervous system changes induced by the tDCS, and develop new methods for the measurement of autonomic nervous system functions.

Enrollment

14 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-65 years
  • Naïve to tDCS
  • Right-handed
  • Beck Anxiety Scores >= 26

Exclusion criteria

  • Metal implants inside skull or eye
  • Severe skin lesions at the electrode placement area
  • History of epilepsy or previous seizures
  • Pregnant or breast-feeding
  • Pacemaker
  • History of intracerebral bleeding during the past six months
  • Lifetime DSM-IV diagnosis of bipolar mood disorder or psychotic disorder
  • DSM-IV diagnosis for substance abuse or dependence during the past six months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

14 participants in 2 patient groups

Treatment 1
Experimental group
Description:
NeuroConn DC Stimulator Plus, tDCS treatment protocol no 1
Treatment:
Device: NeuroConn DC Stimulator Plus, tDCS
Treatment 2
Experimental group
Description:
NeuroConn DC Stimulator Plus, tDCS treatment protocol no 2
Treatment:
Device: NeuroConn DC Stimulator Plus, tDCS

Trial contacts and locations

1

Loading...

Central trial contact

Soili M Lehto, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems